A recent eClinicalMedicine study compares the extent of maintenance of weight loss after one-year termination of active intervention with glucagon-like peptide-1 (GLP-1) receptor agonist, a supervised ...
VIENNA — Exercise to maintain weight loss reduced atherosclerosis progression and improved cardiovascular biomarkers, while GLP-1 therapy alone didn’t, according to a randomized trial in people with ...